Laurie A. Freeman-Gibb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Laurie A. Freeman-Gibb has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Brian J. Zikmund-Fisher
Department of Health Behavior and Health Equity, University of Michigan, Ann Arbor, MI, USA
1 shared publication - Laurel L. Northouse
School of Nursing, University of Michigan, Ann Arbor, MI, United States
1 shared publication - Maria C. Katapodi
Department of Clinical Research, University of Basel, Basel, Switzerland
1 shared publication Nancy K. Janz
University of Michigan School of Public Health, Ann Arbor, MI, USA
1 shared publication
Latest Publications
- 4 May 2016
- Published by Wiley in Psycho-Oncology
- Vol. 26 (9) , 1270-1277
The relationship between illness representations, risk perception and fear of cancer recurrence in breast cancer survivors
Objective Fear of cancer recurrence, although distinct from distress continues to be under‐evaluated, captured, or treated when standard distress scales are used to assess concerns of cancer survivors. We tested a model assessing the association of demographic and clinical factors, illness representations, and perceived risk with fear of cancer recurrence in breast cancer survivors. Methods We recruited 117 breast cancer survivors at least one year after completing breast cancer treatment from Internet discussion boards for this cross‐sectional, descriptive, correlational study. Participants completed a survey that assessed their level of fear of cancer recurrence as well as their illness representations, perceived risk of recurrence, and demographic and medical characteristics. Results Our model explained 62% of the variance in fear of cancer recurrence. Emotional representations (β = .46, p < .01), symptom attribution (β = .21, p < .01), timeline (β = .23, p < .01), and consequences (β = .16, p < .03) were significantly related to fear of recurrence. By contrast, the majority of clinical and demographic variables were not significant contributors to fear of recurrence. Conclusions Upon completion of cancer treatment, survivors with more emotional representations of the experience and those who attribute unrelated symptoms to their breast cancer have a higher level of fear of recurrence. Evaluation of these factors during treatment may help mitigate fear of recurrence in the survivorship phase of the breast cancer trajectory. Copyright © 2016 John Wiley & Sons, Ltd.
- 4 May 2016
- Published by Wiley in Psycho-Oncology
- Vol. 26 (9) , 1270-1277
The relationship between illness representations, risk perception and fear of cancer recurrence in breast cancer survivors
Objective Fear of cancer recurrence, although distinct from distress continues to be under‐evaluated, captured, or treated when standard distress scales are used to assess concerns of cancer survivors. We tested a model assessing the association of demographic and clinical factors, illness representations, and perceived risk with fear of cancer recurrence in breast cancer survivors. Methods We recruited 117 breast cancer survivors at least one year after completing breast cancer treatment from Internet discussion boards for this cross‐sectional, descriptive, correlational study. Participants completed a survey that assessed their level of fear of cancer recurrence as well as their illness representations, perceived risk of recurrence, and demographic and medical characteristics. Results Our model explained 62% of the variance in fear of cancer recurrence. Emotional representations (β = .46, p < .01), symptom attribution (β = .21, p < .01), timeline (β = .23, p < .01), and consequences (β = .16, p < .03) were significantly related to fear of recurrence. By contrast, the majority of clinical and demographic variables were not significant contributors to fear of recurrence. Conclusions Upon completion of cancer treatment, survivors with more emotional representations of the experience and those who attribute unrelated symptoms to their breast cancer have a higher level of fear of recurrence. Evaluation of these factors during treatment may help mitigate fear of recurrence in the survivorship phase of the breast cancer trajectory. Copyright © 2016 John Wiley & Sons, Ltd.